SupplementDrug
2-(AMINOMETHYL)PHENOL clinical trials
Also written 2-HOBA.
Keep track of what changes. Save the 2-(AMINOMETHYL)PHENOL studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 8
Vanderbilt University Medical Center (6) · Metabolic Technologies Inc. (4) · The Miriam Hospital (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1)
Studies
Open first, then newest update. How each study uses 2-(AMINOMETHYL)PHENOL is read from its arms, and is right about nine times in ten.
Testing it · 12
- 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)RecruitingPhase 2Vanderbilt University Medical CenterNCT04941599Written as 2-Hydroxybenzylamine
- Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in HumansNot yet recruitingPhase 2Vanderbilt University Medical CenterNCT07602166Written as 2-hydroxybenzylamine
- Clinical Trial of 2-HOBA in Pulmonary Arterial HypertensionNot yet recruitingPhase 2Vanderbilt University Medical CenterNCT06176118Written as 2-HOBA
- 2-HOBA in Systemic Lupus ErythematosusRecruitingPhase 2Vanderbilt University Medical CenterNCT07225543Written as 2-HOBA acetate (2-Hydroxybenzlamine acetate)
- This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.RecruitingNot applicableMcGill University Health Centre/Research Institute of the McGill University Health CentreNCT07419633Written as 2-hydroxybenzylamine
- 2-HOBA Supplementation in People With Elevated Lipoprotein(a)Not yet recruitingNot applicableThe Miriam HospitalNCT07198009Written as 2-HOBA (Hobamine)
- 2-HOBA Phase 2 Clinical Trial in Rheumatoid ArthritisCompletedPhase 2Vanderbilt University Medical CenterNCT05274243Written as 2-HOBA
- 2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based AblationCompletedPhase 2Vanderbilt University Medical CenterNCT04433091Written as 2-Hydroxybenzylamine
- 2-HOBA: Multiple Dosing Study in Older AdultsCompletedNot applicableMetabolic Technologies Inc.NCT03556319Written as 2-HOBA
- 2-HOBA: Multiple Dosing Study in Healthy HumansCompletedNot applicableMetabolic Technologies Inc.NCT03555682Written as 2-HOBA
- Brain Penetrance of 2-HOBA in HumansCompletedNot applicableMetabolic Technologies Inc.NCT03554096Written as 2-HOBA
- 2-HOBA: Initial Evaluation in HumansCompletedNot applicableMetabolic Technologies Inc.NCT03176940Written as 2-HOBA
Codes
What other systems call 2-(AMINOMETHYL)PHENOL · ClinicalTrials.gg INT015227
- MeSH (NLM) C0324162-(aminomethyl)phenolOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C032416 | 2-(aminomethyl)phenol | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.